Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 1;33(suppl_3):iii28-iii34.
doi: 10.1093/ndt/gfy174.

Cardiovascular disease in dialysis patients

Mario Cozzolino  1 , Michela Mangano  1 , Andrea Stucchi  1 , Paola Ciceri  2 , Ferruccio Conte  1 , Andrea Galassi  1
Affiliations
Review

Cardiovascular disease in dialysis patients

Mario Cozzolino et al. Nephrol Dial Transplant. .

Abstract

Cardiovascular disease (CVD) is a highly common complication and the first cause of death in patients with end-stage renal disease (ESRD) on haemodialysis (HD). In this population, mortality due to CVD is 20 times higher than in the general population and the majority of maintenance HD patients have CVD. This is likely due to ventricular hypertrophy as well as non-traditional risk factors, such as chronic volume overload, anaemia, inflammation, oxidative stress, chronic kidney disease-mineral bone disorder and other aspects of the 'uraemic milieu'. Better understanding the impact of these numerous factors on CVD would be an important step for prevention and treatment. In this review we focus non-traditional CVD risk factors in HD patients.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Cardiovascular disease in dialysis.
See this image and copyright information in PMC

References

    1. Fox CS, Matsushita K, Woodward M. et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis of 1 024 977 individuals. Lancet 2012; 380: 1662–1673 - PMC - PubMed
    1. Mahmoodi BK, Matsushita K, Woodward M. et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012; 380: 1649–1661 - PMC - PubMed
    1. Cozzolino M, Galassi A, Pivari F. et al. The cardiovascular burden in end-stage renal disease. Contrib Nephrol 2017; 191: 44–57 - PubMed
    1. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR. et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339–352 - PubMed
    1. Herzog CA, Asinger RW, Berger AK. et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011; 80: 572–586 - PubMed

Publication types

MeSH terms